FCA authorised · FRN 724952 0117 325 0027Quote & buy →
Medical & aesthetics
Botox and filler insurance is the treatment liability or malpractice cover that injectors, prescribers and clinics need for cosmetic injectables. It matters because botulinum toxin is a prescription-only medicine, so insurers look hard at who prescribed, who injected, whether the prescriber saw the client in person and where the product came from.
Part of: Aesthetic clinic insurance
In short
Botulinum toxin is a prescription-only medicine, so a doctor, nurse, pharmacist or other prescriber must be involved in every treatment. The GMC, NMC and GPhC all say these medicines must not be prescribed remotely: the prescriber must see the client face to face. In England it is an offence to give toxin or cosmetic filler injections to under-18s. Doctors must by law hold indemnity cover, the NMC expects nurse prescribers to have appropriate indemnity, and the GPhC requires pharmacist prescribers to have PI for all their cosmetic work. Insurers usually want named procedures, recognised training, a named prescriber, licensed products, consent and records.
Last reviewed 7 October 2026 by the Apex professional indemnity team.
Botulinum toxin is a prescription-only medicine. The MHRA says it should only be sold or supplied in line with a prescription from an appropriate prescriber, such as a doctor or another qualified healthcare professional. So every toxin treatment has a prescriber behind it, even when someone else holds the needle.
The regulators for doctors, nurses and pharmacists all now say the prescriber must see the client in person first.
| Regulator | Who it covers | Position on remote prescribing |
|---|---|---|
| GMC | Doctors | Paragraph 25 of its prescribing guidance: doctors must physically examine patients before prescribing non-surgical cosmetic medicines such as injectable toxins, so they must not prescribe them remotely. |
| NMC | Nurse and midwife prescribers | From 1 June 2025, a face-to-face consultation and a documented clinical assessment are required before prescribing any product for an elective non-surgical cosmetic procedure. Telephone, email, online, video or third-party methods are not appropriate, for first and follow-up consultations alike. |
| GPhC | Pharmacist prescribers | Non-surgical cosmetic products may be prescribed and administered only after a physical examination, so a remote consultation is not appropriate. |
For insurance this is not a side issue. A treatment carried out on the back of a video call or a questionnaire sits outside the prescriber’s professional guidance, and that is exactly what an insurer will probe after a complaint.
Many treatments involve three parties. Each carries its own legal duties and needs its own cover, or a clear written agreement about whose policy responds.
| Role | What they do | Duties worth knowing | Cover usually needed |
|---|---|---|---|
| Prescriber | Assesses the client in person, decides whether the medicine is suitable and issues the prescription or direction | The NMC and GPhC say the prescriber stays responsible for oversight and the outcome even when administration is delegated. Doctors with a licence to practise must hold an indemnity arrangement under section 44C of the Medical Act 1983. | Their own medical malpractice or PI cover, written for prescribing in aesthetics |
| Injector | Administers the product in line with the prescriber’s directions | The GPhC says pharmacist prescribers may delegate only to a healthcare professional with the right training. The NMC expects the person to be qualified and competent, at suitable premises. | Treatment liability or malpractice cover naming each procedure they perform |
| Clinic or business owner | Runs the premises, books clients, buys and stores stock, employs or engages staff | In England, a business owner commits an offence if a non-approved person gives toxin or filler to an under-18 (Botulinum Toxin and Cosmetic Fillers (Children) Act 2021, s.2), subject to a due diligence defence | Public and products liability, employers’ liability if it has staff, and a treatment risks policy for the business itself |
Gaps tend to open where one person assumes another’s policy covers them. A clinic owner who books a visiting prescriber, for example, should not assume the prescriber’s cover protects the clinic, or the injector.
The under-18 ban. Section 1 of the Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 makes it an offence to give botulinum toxin, or a filler injection for a cosmetic purpose, to a person under 18 in England. It came into force on 1 October 2021. There is a defence for a registered medical practitioner, for a regulated health professional acting on a doctor’s directions, and for someone who took reasonable steps to check age and reasonably believed the client was 18 or over. The penalty is a fine.
Insurers commonly exclude treatment that breaks the law, so a weak age-check process is an insurance problem as well as a legal one.
The licensing power. Section 180 of the Health and Care Act 2022, in force since 1 July 2022, lets the Secretary of State make regulations requiring a personal licence to carry out specified cosmetic procedures in England in the course of business, and a premises licence for where they happen. The Act defines cosmetic procedures to include injections. Check GOV.UK for whether regulations have been made and what they say before relying on any scheme.
Most claims allege bodily injury, disfigurement or distress after a treatment. Which policy answers depends on who did what. This is general, and every policy is subject to its own terms.
| What goes wrong | Cover usually engaged | Where gaps often appear |
|---|---|---|
| Poor technique or wrong placement | Treatment liability or malpractice cover for the injector | Procedures not named on the schedule; training below what the policy requires |
| Unsuitable prescribing or a missed contraindication | The prescriber’s own malpractice or PI cover | Remote prescribing against regulator guidance; prescribing outside the prescriber’s competence |
| Serious complication such as a vascular occlusion after filler | Treatment or malpractice cover, if the procedure is covered | No documented consent or complication protocol; delayed follow-up |
| A faulty, unlicensed or counterfeit product | Products liability, sometimes within the treatment policy | Unlicensed or unauthorised products are commonly excluded |
| Client slips in the waiting room | Public liability | None specific, but check the limit fits the premises |
| Under-18 treated in breach of the 2021 Act | Possibly none | Illegal acts and fines are commonly excluded |
Complications. Filler and toxin treatments can, uncommonly, lead to serious harm. The MHRA’s July 2026 Drug Safety Update said iatrogenic botulism has rarely been reported after botulinum toxin use, and that the risk may be higher with counterfeit or unauthorised products. Insurers therefore ask how complications are recognised, who is on call and how clients are followed up. They do not expect clinical detail on the proposal, only evidence that a plan exists.
Products. Buying stock through informal channels is a common reason for cover to fail. The MHRA says supplying unlicensed botulinum toxin can lead to up to two years in prison and unlimited fines under the Human Medicines Regulations 2012.
Claims-made or occurrence. Many treatment and malpractice policies are written on a claims-made basis, so the policy in force when the complaint arrives responds. Check which basis yours uses, and if you stop injecting, ask about run-off cover.
A non-medic cannot prescribe it. Whether they can be the injector depends on the prescriber and their regulator. A pharmacist prescriber can delegate administration only to a healthcare professional. A nurse or midwife prescriber must be satisfied the person is qualified and competent. Either way, the prescriber must have seen the client face to face first.
Treatment cover for non-medical injectors does exist, but it usually comes with conditions: recognised training for each named procedure, a named prescriber who examines each client in person, licensed products from a legitimate supplier, written consent and full records.
If this affects your business, these are the points a broker will ask about:
Speak to a broker
Aesthetics cover, reviewed by a named broker
Start the online proposal and save it as you go, or leave your number and a named broker will call you back, usually the same working day.
Apex Insurance Brokers is an independent insurance broker based in Bristol, established in 2009 and authorised and regulated by the Financial Conduct Authority. We are not tied to one insurer: we work with over 30 markets, including Lloyd’s syndicates through wholesale brokers, and every client has a named broker who handles the placement, mid-term changes, certificates for clients and the renewal.
In practice, yes. Doctors must by law hold an indemnity arrangement for their practice, the NMC expects nurse prescribers to have appropriate indemnity cover, and the GPhC requires pharmacist prescribers to have PI covering all their cosmetic work. Prescribers, clinics and training providers commonly insist that injectors carry their own treatment cover before they will work with them.
A non-medic cannot prescribe botulinum toxin, because it is a prescription-only medicine. Whether they can administer it depends on the prescriber: GPhC guidance lets pharmacist prescribers delegate only to healthcare professionals, while the NMC requires nurse prescribers to be satisfied the person is qualified and competent. The prescriber must see each client face to face.
Not under current regulator guidance. The GMC says doctors must physically examine patients before prescribing non-surgical cosmetic medicines. The NMC has required a face-to-face consultation since 1 June 2025. The GPhC says pharmacist prescribers must carry out a physical examination first. Treatments that rely on remote prescribing can leave everyone involved exposed.
In England, yes. The Botulinum Toxin and Cosmetic Fillers (Children) Act 2021 made it an offence from 1 October 2021 to give botulinum toxin, or a cosmetic filler injection, to anyone under 18. There are limited defences, including for doctors and for regulated health professionals acting on a doctor’s directions.
Usually not. A prescriber’s malpractice or PI policy is written to protect the prescriber for their own decisions. As the person administering the treatment, you normally need your own treatment liability or malpractice cover, and the clinic needs its own policy too. Agree in writing who does what.
It may, if the procedure is named on your policy and you met its conditions on training, prescribing, consent and products. Insurers commonly decline or limit claims where the product was unlicensed, the prescriber never saw the client, or records are missing. Check your wording and tell your broker about any change in what you offer.
Our online treatment proposal takes about five minutes, and a named Apex broker reviews it and comes back to you about cover for your prescribers, injectors and clinic. Or call 0117 325 0027.
Start your treatment proposal Call 0117 325 0027Apex Insurance Brokers Limited is authorised and regulated by the Financial Conduct Authority. Registered in England and Wales, company number 07014570. This page is general information, not advice on your individual circumstances. Cover is always subject to the insurer’s acceptance and the policy terms, and this page does not guarantee that cover will be available or on what terms.
